Kameshwar Singh
Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Receptors, Aryl Hydrocarbon | 6 | 2008 | 23 |
Why?
|
Hematopoietic Stem Cells | 6 | 2008 | 69 |
Why?
|
Schistosomiasis mansoni | 3 | 2002 | 4 |
Why?
|
Hematopoiesis | 2 | 2009 | 47 |
Why?
|
Tetrachlorodibenzodioxin | 3 | 2008 | 18 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 14 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 48 |
Why?
|
Bone Marrow | 1 | 2010 | 109 |
Why?
|
Carcinogens | 1 | 2008 | 40 |
Why?
|
Stem Cells | 2 | 2008 | 107 |
Why?
|
Liver Diseases, Parasitic | 1 | 2005 | 2 |
Why?
|
Granuloma | 1 | 2005 | 38 |
Why?
|
Praziquantel | 1 | 2004 | 3 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 9 |
Why?
|
Anthelmintics | 1 | 2004 | 5 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 24 |
Why?
|
Liver Cirrhosis | 1 | 2004 | 48 |
Why?
|
Gene Therapy | 1 | 2005 | 89 |
Why?
|
Cell Proliferation | 3 | 2008 | 227 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 204 |
Why?
|
Mice | 8 | 2001 | 623 |
Why?
|
Cell Cycle | 4 | 2000 | 121 |
Why?
|
Cell Count | 3 | 2001 | 163 |
Why?
|
Cell Lineage | 2 | 2008 | 60 |
Why?
|
Mice, Inbred C57BL | 4 | 2008 | 318 |
Why?
|
Animals | 11 | 2001 | 1031 |
Why?
|
Mice, Inbred CBA | 2 | 2004 | 41 |
Why?
|
Gene Expression | 2 | 2004 | 291 |
Why?
|
Circadian Rhythm | 2 | 2010 | 50 |
Why?
|
Spleen | 2 | 2004 | 129 |
Why?
|
Xenobiotics | 2 | 2008 | 14 |
Why?
|
Bromodeoxyuridine | 1 | 2010 | 47 |
Why?
|
Up-Regulation | 2 | 2002 | 183 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2001 | 113 |
Why?
|
Cytokines | 2 | 2004 | 207 |
Why?
|
Alleles | 1 | 2010 | 108 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2010 | 119 |
Why?
|
Benzene | 1 | 2009 | 7 |
Why?
|
Leukocytes | 1 | 2010 | 94 |
Why?
|
Erythrocytes | 1 | 2010 | 109 |
Why?
|
Cell Movement | 1 | 2011 | 163 |
Why?
|
Mice, Knockout | 1 | 2010 | 265 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 138 |
Why?
|
DNA Primers | 1 | 2008 | 208 |
Why?
|
Cell Division | 3 | 2000 | 273 |
Why?
|
Female | 5 | 2001 | 1643 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 279 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 243 |
Why?
|
Receptors, Interleukin-2 | 1 | 2005 | 31 |
Why?
|
Retroviridae | 1 | 2005 | 36 |
Why?
|
Forkhead Transcription Factors | 1 | 2005 | 44 |
Why?
|
Hydroxyproline | 1 | 2004 | 16 |
Why?
|
T-Lymphocyte Subsets | 1 | 2005 | 70 |
Why?
|
Organ Size | 1 | 2004 | 118 |
Why?
|
Base Sequence | 1 | 2008 | 371 |
Why?
|
Body Weight | 1 | 2004 | 178 |
Why?
|
Genetic Vectors | 1 | 2005 | 139 |
Why?
|
Ovum | 1 | 2002 | 11 |
Why?
|
Antigens, Helminth | 1 | 2002 | 5 |
Why?
|
Schistosoma mansoni | 1 | 2002 | 5 |
Why?
|
Collagen | 1 | 2004 | 118 |
Why?
|
Isoantigens | 1 | 2001 | 18 |
Why?
|
Signal Transduction | 1 | 2011 | 313 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 47 |
Why?
|
Lymphokines | 1 | 2002 | 61 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 64 |
Why?
|
Arsenites | 1 | 2000 | 6 |
Why?
|
Cells, Cultured | 2 | 2001 | 447 |
Why?
|
Lead | 1 | 2001 | 55 |
Why?
|
Liver | 1 | 2004 | 248 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 139 |
Why?
|
Cell Differentiation | 1 | 2000 | 262 |
Why?
|
Apoptosis | 1 | 2000 | 265 |
Why?
|
Humans | 5 | 2000 | 1856 |
Why?
|
Protein Transport | 1 | 2011 | 101 |
Why?
|
Carcinogens, Environmental | 1 | 2010 | 6 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2010 | 9 |
Why?
|
Antigens, CD8 | 1 | 2010 | 25 |
Why?
|
Hematopoietic System | 1 | 2010 | 9 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 57 |
Why?
|
Hematologic Diseases | 1 | 2010 | 23 |
Why?
|
Retinoblastoma Protein | 1 | 2010 | 26 |
Why?
|
Antigens, CD3 | 1 | 2010 | 37 |
Why?
|
Antigens, CD4 | 1 | 2010 | 29 |
Why?
|
Male | 1 | 2008 | 1553 |
Why?
|
Cell Hypoxia | 1 | 2010 | 31 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2010 | 55 |
Why?
|
Thymus Gland | 1 | 2010 | 57 |
Why?
|
Immune System | 1 | 2010 | 43 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 90 |
Why?
|
Ligands | 1 | 2010 | 116 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 135 |
Why?
|
Disease Progression | 1 | 2010 | 244 |
Why?
|
Inflammation | 1 | 2010 | 208 |
Why?
|
RNA | 1 | 2010 | 126 |
Why?
|
Transcription, Genetic | 1 | 2010 | 253 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 39 |
Why?
|
Neoplasms | 1 | 2010 | 239 |
Why?
|
Superantigens | 1 | 2001 | 5 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2001 | 21 |
Why?
|
RNA, Messenger | 1 | 2010 | 394 |
Why?
|
Mitogens | 1 | 2001 | 31 |
Why?
|
Immunophenotyping | 1 | 2001 | 66 |
Why?
|
Mice, Inbred Strains | 1 | 2001 | 118 |
Why?
|
U937 Cells | 1 | 2000 | 16 |
Why?
|
DNA Fragmentation | 1 | 2000 | 35 |
Why?
|
Immunologic Memory | 1 | 2001 | 51 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 94 |
Why?
|
Caspase 3 | 1 | 2000 | 56 |
Why?
|
Calcitriol | 1 | 2000 | 29 |
Why?
|
Caspases | 1 | 2000 | 58 |
Why?
|
Antigens, CD | 1 | 2001 | 128 |
Why?
|
Flow Cytometry | 1 | 2001 | 216 |
Why?
|
Cell Survival | 1 | 2000 | 229 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 431 |
Why?
|
Time Factors | 1 | 2000 | 896 |
Why?
|
